Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

CGP 39653

Known as: 3-Heptenoic acid, 2-amino-4-(phosphonomethyl)-, (E)-(+-)-, CGP-39653 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2005
2005
SummaryTo analyze the affect of blocking neuronal activity on NMDA receptor levels during development, we have injected chick… Expand
  • figure 1
  • table 1
Is this relevant?
2005
2005
Perzinfotel [EAA-090; [2-(8,9-dioxo-2,6-diazabicyclo[5.2.0]non-1(7)-en-2-yl)-ethyl]phosphonic acid] is a selective, competitive N… Expand
Is this relevant?
1996
1996
Antisense oligodeoxynucleotides were used to determine whether alterations in the expression of N-methyl-D-aspartate (NMDA… Expand
Is this relevant?
1995
1995
Glutathione, both reduced (GSH) and oxidized (GSSG), was effective in displacing binding of L-[3H]-glutamic acid (L-[3H]Glu) and… Expand
Is this relevant?
1995
1995
L-trans-Pyrrolidine-2,4-dicarboxylate (L-t-PDC) and L-threo-3- hydroxyaspartate (L-t-3OHA), compounds known to interact strongly… Expand
Is this relevant?
Highly Cited
1994
Highly Cited
1994
The ligand preferences of recombinant NR1 homomeric and NR1-NR2 heteromeric NMDA receptors were examined by homogenate binding… Expand
Is this relevant?
1994
1994
Chronic treatment of adult rats with DL-(E)-2-amino-4-methyl-5-phosphono-3-pentenoic carboxyethylester (CGP 39551) (30 mg/kg… Expand
Is this relevant?
1993
1993
D,L-(E)-2-Amino-4-propyl-5-phosphono-3-pentenoic acid (CGP 39653), a new, high-affinity, selective NMDA receptor antagonist… Expand
Is this relevant?
1993
1993
Treatment with a low concentration of Triton X-100 almost tripled the binding of [3H]D,L-(E)-2-amino-4-propyl-5-phosphono-3… Expand
Is this relevant?
Highly Cited
1991
Highly Cited
1991
CGP 39653 (D,L-(E)-2-amino-4-propyl-5-phosphono-3-pentenoic acid) was initially discovered to inhibit the binding of [3H]L… Expand
Is this relevant?